title: Industry reneges on postmarketing trial commitments.
authors.forename: Aaron
authors.initials: A
authors.lastname: Bouchie
mesh_terms: D017327:Clinical Trials, Phase IV as Topic / Q000331:legislation & jurisprudence* / Q000639:trends*; D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000458:organization & administration* / Q000639:trends*; D019983:Guideline Adherence / Q000331:legislation & jurisprudence / Q000458:organization & administration* / Q000639:trends; D011358:Product Surveillance, Postmarketing / Q000379:methods / Q000592:standards* / Q000639:trends*; D012941:Social Responsibility; D014481:United States